Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

por Metelo, Ana M., Jozwik, Agnieszka, Luong, Le Anh, Dominey-Foy, Delaney, Graham, Charlotte, Attwood, Charlotte, Inam, Shafqat, Dunlop, Alan, Sanchez, Katy, Cuthill, Kirsty, Rice, Carmel, Streetly, Matthew, Bentley, Trevor, Boldajipour, Bijan, Sommer, Cesar, Sasu, Barbra, Benjamin, Reuben
Publicado 2022